2021

  • Esther Lee, BSc: Educational tool to increase SLE patients’ knowledge of preeclampsia

    Esther Lee, BSc: Educational tool to increase SLE patients’ knowledge of preeclampsia

    Joo Young (Esther) Lee, BSc, will present the poster “Increasing Preeclampsia Knowledge in SLE with a Specific Educational Tool: Preliminary Results” during Tuesday morninng’s Poster Session D.

  • Keynote Address: Targeted communication needed to improve public health

    Keynote Address: Targeted communication needed to improve public health

    Emmy Award-winning journalist, educator, and poet Seema Yasmin, MD, discussed the “covidization” of rheumatology during the Opening Session of ACR Convergence 2021.

  • Presidential Address: ACR maintains forward momentum in challenging times

    Presidential Address: ACR maintains forward momentum in challenging times

    “Despite all that has happened in the last 20 months, the ACR, its members, and our global rheumatology community have accomplished things that are not just normal, they are truly amazing,” said ACR President David R. Karp, MD, PhD, during his Presidential Address Friday.

  • Year in Review session previews potential of new, engineered treatment pathways

    Year in Review session previews potential of new, engineered treatment pathways

    Messenger RNA vaccines were a hot topic during Friday’s Year in Review session. Michael Brenner, MD, discussed basic science advances during the session and Karen H. Costenbader, MD, MPH, reviewed clinical research findings from the past year.

  • Challenges remain to better address rheumatologic disorders globally

    Challenges remain to better address rheumatologic disorders globally

    Three of rheumatology’s global leaders — Dzifa Ida Dey, MD, MSc, FACR, Manuel F. Ugarte-Gil, MD, MSc, and Arvind Chopra, MD, MBBS, FRCP — discussed challenges and innovation in global rheumatology research on Saturday.

  • Researchers share molecular insights from second phase of AMP

    Researchers share molecular insights from second phase of AMP

    The Accelerating Medicines Partnership is beginning to outline molecular features of rheumatoid arthritis that could have direct clinical impact. Four researchers shared the latest findings from AMP Phase 2 on Saturday.

  • Pediatric rheumatologists discuss osteoporosis in children with chronic inflammatory diseases

    Pediatric rheumatologists discuss osteoporosis in children with chronic inflammatory diseases

    Leanne Ward, MD, FRCPC, and Emily von Scheven, MD, MAS, reviewed the most recent advances and recommendations in the diagnosis, monitoring, and management of bone fragility in children with chronic inflammatory illnesses during a Saturday session.

  • Timothy Edgil, MD: Trends in DXA utilization in the U.S.

    Timothy Edgil, MD: Trends in DXA utilization in the U.S.

    Timothy Edgil, MD, will present the poster “Assessing Trends in Dual Energy X-Ray Absorptiometry (DXA) Utilization Among Medical Providers in the United States” during Monday morning’s Poster Session C.

  • Rachel Robbins, MD: Rheumatology continuing professional development for PCPs

    Rachel Robbins, MD: Rheumatology continuing professional development for PCPs

    Rachel Robbins, MD, will present the poster “Rheumatology Continuing Professional Development for Primary Care Providers: A Systematic Review” during Monday morning’s Poster Session C.

  • Rebecca Fitzpatrick, MD: Marijuana use by rheumatology patients

    Rebecca Fitzpatrick, MD: Marijuana use by rheumatology patients

    Rebecca Fitzpatrick, MD, will present the poster “Marijuana Use Amongst Rheumatology Patients: It’s More Common Than Rheumatologists Believe” during Monday morning’s Poster Session C.